Cleveland Biolabs (CBLI) Receives USPTO Notice of Allowance for Two Entolimod Patents
Tweet Send to a Friend
Cleveland Biolabs (NASDAQ: CBLI) announced the allowance of two new patent applications by the U.S. Patent Office with claims that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
